Why do we need new and better antidepressants?
- 1 February 2006
- journal article
- research article
- Published by Wolters Kluwer Health in International Clinical Psychopharmacology
- Vol. 21 (Supplement) , S1-S10
- https://doi.org/10.1097/01.yic.0000199455.39552.1c
Abstract
The range of available antidepressants is reviewed in relation to mechanisms of action and the evidence of efficacy in general and efficacy in severe depression in particular. In studies investigating efficacy in major depressive disorder, not all antidepressants have been shown to have clear-cut efficacy in severe depression. Here, the minimum standards for the necessary methodology to investigate efficacy in severe depression are reviewed and the methods that are needed to establish efficacy as a superior antidepressant or as an antidepressant with a faster than expected response are suggested. A review of the mechanisms of action of different antidepressants is accompanied by a critical review of the properties of an antidepressant likely to achieve either efficacy in severe depression or the status of a superior antidepressant.Keywords
This publication has 74 references indexed in Scilit:
- Suicide in 406 Mood-Disorder Patients With and Without Long-Term Medication: A 40 to 44 Years' Follow-UpArchives of Suicide Research, 2005
- Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorderInternational Clinical Psychopharmacology, 2005
- A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgiaHuman Psychopharmacology: Clinical and Experimental, 2004
- A double‐blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorderArthritis & Rheumatism, 2004
- Mirtazapine Orally Disintegrating Tablet Versus Sertraline: A Prospective Onset of Action StudyJournal of Clinical Psychopharmacology, 2003
- Early onset of action of mirtazapine versus other new-generation antidepressants for patients in remissionEuropean Neuropsychopharmacology, 2002
- Discontinuation Symptoms After Treatment With Serotonin Reuptake InhibitorsThe Journal of Clinical Psychiatry, 1997
- Milnacipran and selective serotonin reuptake inhibitors in major depressionInternational Clinical Psychopharmacology, 1996
- Antidepressant Withdrawal SyndromeCNS Drugs, 1996
- The place of obsessive compulsive disorder in the diagnostic hierarchyInternational Clinical Psychopharmacology, 1992